On Monday, Bio-Techne Corp (NASDAQ: TECH) was -1.37% drop from the session before settling in for the closing price of $50.49. A 52-week range for TECH has been $46.01 – $85.57.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 10.61% over the past five years. When this article was written, the company’s average yearly earnings per share was at 6.57%. With a float of $156.31 million, this company’s outstanding shares have now reached $157.92 million.
Let’s look at the performance matrix of the company that is accounted for 3100 employees. In terms of profitability, gross margin is 65.8%, operating margin of 19.93%, and the pretax margin is 15.53%.
Bio-Techne Corp (TECH) Insider and Institutional Ownership
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Bio-Techne Corp stocks. The insider ownership of Bio-Techne Corp is 1.12%, while institutional ownership is 100.59%. The most recent insider transaction that took place on Feb 14 ’25, was worth 122,691. In this transaction Director of this company sold 1,860 shares at a rate of $65.96, taking the stock ownership to the 1,976 shares. Before that another transaction happened on Feb 14 ’25, when Company’s Domestic Partner of Director proposed sale 1,860 for $65.96, making the entire transaction worth $122,691.
Bio-Techne Corp (TECH) Latest Financial update
Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.53 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 6.57% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 12.43% during the next five years compared to 11.13% growth over the previous five years of trading.
Bio-Techne Corp (NASDAQ: TECH) Trading Performance Indicators
You can see what Bio-Techne Corp (TECH) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 2.77. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 6.58. Likewise, its price to free cash flow for the trailing twelve months is 30.96.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 0.98, a number that is poised to hit 0.51 in the next quarter and is forecasted to reach 2.16 in one year’s time.
Technical Analysis of Bio-Techne Corp (TECH)
Bio-Techne Corp (NASDAQ: TECH) saw its 5-day average volume 1.54 million, a negative change from its year-to-date volume of 1.76 million. As of the previous 9 days, the stock’s Stochastic %D was 41.45%. Additionally, its Average True Range was 2.45.
During the past 100 days, Bio-Techne Corp’s (TECH) raw stochastic average was set at 11.39%, which indicates a significant decrease from 50.31% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 30.50% in the past 14 days, which was lower than the 42.84% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $56.50, while its 200-day Moving Average is $69.57. Nevertheless, the first resistance level for the watch stands at $50.66 in the near term. At $51.53, the stock is likely to face the second major resistance level. The third major resistance level sits at $52.01. If the price goes on to break the first support level at $49.31, it is likely to go to the next support level at $48.83. The third support level lies at $47.96 if the price breaches the second support level.
Bio-Techne Corp (NASDAQ: TECH) Key Stats
There are 158,088K outstanding shares of the company, which has a market capitalization of 7.87 billion. As of now, sales total 1,159 M while income totals 168,110 K. Its latest quarter income was 297,030 K while its last quarter net income were 34,890 K.
